The role of CD22 and other inhibitory co-receptors in B-cell activation

Current Opinion in Immunology

Volumn 17, Issue 3, 2005, Pages 290-297

  Nitschke, Lars ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; CALCIUM; CD22 ANTIGEN; CD72 ANTIGEN; FC RECEPTOR; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; IMMUNOGLOBULIN M; IMMUNOGLOBULIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOLIPASE C GAMMA; PROTEIN KINASE SYK; PROTEIN TYROSINE PHOSPHATASE SHP 2;

ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; APOPTOSIS; B LYMPHOCYTE ACTIVATION; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL LINEAGE; IMMUNOGLOBULIN PRODUCTION; IMMUNOREGULATION; LIGAND BINDING; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MOLECULAR INTERACTION; MOLECULAR RECOGNITION; NONHUMAN; PROTEIN AGGREGATION; PROTEIN CROSS LINKING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; REVIEW; SIALYLATION; SIGNAL TRANSDUCTION; TARGET CELL; UPREGULATION;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD22; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; B-LYMPHOCYTES; CELL ADHESION MOLECULES; HUMANS; LECTINS; LYMPHOCYTE ACTIVATION; MICE; RECEPTORS, ANTIGEN, B-CELL; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION;

EID: 18844424394     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2005.03.005     Document Type: Review

References (60)

1. G.M. Doody, L.B. Justement, C.C. Delibrias, R.J. Matthews, J. Lin, M.L. Thomas, and D.T. Fearon A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP Science 269 1995 242 244
2. L. Nitschke, R. Carsetti, B. Ocker, G. Kohler, and M.C. Lamers CD22 is a negative regulator of B-cell receptor signalling Curr Biol 7 1997 133 143
3. T.L. O'Keefe, G.T. Williams, S.L. Davies, and M.S. Neuberger Hyperresponsive B cells in CD22-deficient mice Science 274 1996 798 801
4. K.L. Otipoby, K.B. Andersson, K.E. Draves, S.J. Klaus, A.G. Farr, J.D. Kerner, R.M. Perlmutter, C.L. Law, and E.A. Clark CD22 regulates thymus-independent responses and the lifespan of B cells Nature 384 1996 634 637
5. S. Sato, A.S. Miller, M. Inaoki, C.B. Bock, P.J. Jansen, M.L. Tang, and T.F. Tedder CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: altered signalling in CD22-deficient mice Immunity 5 1996 551 562
6. S. Sato, P.J. Jansen, and T.F. Tedder CD19 and CD22 expression reciprocally regulates tyrosine phosphorylation of Vav protein during B lymphocyte signalling Proc Natl Acad Sci USA 94 1997 13158 13162
7. M. Fujimoto, A.P. Bradney, J.C. Poe, D.A. Steeber, and T.F. Tedder Modulation of B lymphocyte antigen receptor signal transduction by a CD19/CD22 regulatory loop Immunity 11 1999 191 200
8. J. Gerlach, S. Ghosh, H. Jumaa, M. Reth, J. Wienands, A.C. Chan, and L. Nitschke B cell defects in SLP65/BLNK-deficient mice can be partially corrected by the absence of CD22, an inhibitory coreceptor for BCR signalling Eur J Immunol 33 2003 3418 3426
9. -/- mice.
10. C.L. Law, S.P. Sidorenko, K.A. Chandran, Z. Zhao, S.H. Shen, E.H. Fischer, and E.A. Clark CD22 associates with protein tyrosine phosphatase 1C, Syk, and phospholipase C-gamma(1) upon B cell activation J Exp Med 183 1996 547 560
11. J. Yohannan, J. Wienands, K.M. Coggeshall, and L.B. Justement Analysis of tyrosine phosphorylation-dependent interactions between stimulatory effector proteins and the B cell co-receptor CD22 J Biol Chem 274 1999 18769 18776
12. J.C. Poe, M. Fujimoto, P.J. Jansen, A.S. Miller, and T.F. Tedder CD22 forms a quaternary complex with SHIP, Grb2, and Shc. A pathway for regulation of B lymphocyte antigen receptor-induced calcium flux J Biol Chem 275 2000 17420 17427
13. B. Stork, M. Engelke, J. Frey, V. Horejsi, A. Hamm-Baarke, B. Schraven, T. Kurosaki, and J. Wienands Grb2 and the non-T cell activation linker NTAL constitute a Ca(2+)-regulating signal circuit in B lymphocytes Immunity 21 2004 681 691
14. T. Samardzic, D. Marinkovic, C.P. Danzer, J. Gerlach, L. Nitschke, and T. Wirth Reduction of marginal zone B cells in CD22-deficient mice Eur J Immunol 32 2002 561 567
15. K.L. Otipoby, K.E. Draves, and E.A. Clark CD22 regulates B cell receptor-mediated signals via two domains that independently recruit Grb2 and SHP-1 J Biol Chem 276 2001 44315 44322
16. D.M. Mills, J.C. Stolpa, and J.C. Cambier Cognate B cell signalling via MHC class II: differential regulation of B cell antigen receptor and MHC class II/Ig-alpha beta signalling by CD22 J Immunol 172 2004 195 201
17. C. Wakabayashi, T. Adachi, J. Wienands, and T. Tsubata A distinct signalling pathway used by the IgG-containing B cell antigen receptor Science 298 2002 2392 2395
18. T.R. Bakker, C. Piperi, E.A. Davies, and P.A. Merwe Comparison of CD22 binding to native CD45 and synthetic oligosaccharide Eur J Immunol 32 2002 1924 1932
19. N. Razi, and A. Varki Masking and unmasking of the sialic acid-binding lectin activity of CD22 (Siglec-2) on B lymphocytes Proc Natl Acad Sci USA 95 1998 7469 7474
20. B.E. Collins, O. Blixt, N.V. Bovin, C.P. Danzer, D. Chui, J.D. Marth, L. Nitschke, and J.C. Paulson Constitutively unmasked CD22 on B cells of ST6Gal I knockout mice: novel sialoside probe for murine CD22 Glycobiology 12 2002 563 571
21. C.P. Danzer, B.E. Collins, O. Blixt, J.C. Paulson, and L. Nitschke Transitional and marginal zone B cells have a high proportion of unmasked CD22: implications for BCR signalling Int Immunol 15 2003 1137 1147
22. L. Jin, P.A. McLean, B.G. Neel, and H.H. Wortis Sialic acid binding domains of CD22 are required for negative regulation of B cell receptor signalling J Exp Med 195 2002 1199 1205
23. S. Kelm, J. Gerlach, R. Brossmer, C.P. Danzer, and L. Nitschke The ligand-binding domain of CD22 is needed for inhibition of the B cell receptor signal, as demonstrated by a novel human CD22-specific inhibitor compound J Exp Med 195 2002 1207 1213
24. ••]).
25. M. Zhang, and A. Varki Cell surface sialic acids do not affect primary CD22 interactions with CD45 and surface IgM nor the rate of constitutive CD22 endocytosis Glycobiology 14 2004 939 949
26. A. Lanoue, F.D. Batista, M. Stewart, and M.S. Neuberger Interaction of CD22 with alpha2,6-linked sialoglycoconjugates: innate recognition of self to dampen B cell autoreactivity? Eur J Immunol 32 2002 348 355
27. B.E. Collins, O. Blixt, A.R. DeSieno, N. Bovin, J.D. Marth, and J.C. Paulson Masking of CD22 by cis ligands does not prevent redistribution of CD22 to sites of cell contact Proc Natl Acad Sci USA 101 2004 6104 6109
28. T. Adachi, H. Flaswinkel, H. Yakura, M. Reth, and T. Tsubata The B cell surface protein CD72 recruits the tyrosine phosphatase SHP-1 upon tyrosine phosphorylation J Immunol 160 1998 4662 4665
29. T. Adachi, C. Wakabayashi, T. Nakayama, H. Yakura, and T. Tsubata CD72 negatively regulates signalling through the antigen receptor of B cells J Immunol 164 2000 1223 1229
30. Y. Wu, M.J. Nadler, L.A. Brennan, G.D. Gish, J.F. Timms, N. Fusaki, J. Jongstra Bilen, N. Tada, T. Pawson, and J. Wither The B-cell transmembrane protein CD72 binds to and is an in vivo substrate of the protein tyrosine phosphatase SHP-1 Curr Biol 8 1998 1009 1017
31. Y. Hokazono, T. Adachi, M. Wabl, N. Tada, T. Amagasa, and T. Tsubata Inhibitory co-receptors activated by antigens but not by anti-immunoglobulin heavy chain antibodies install requirement of co-stimulation through CD40 for survival and proliferation of b cells J Immunol 171 2003 1835 1843 The authors show that antigenic B-cell stimulation results in efficient phosphorylation of inhibitory receptors CD72 and CD22, which is not the case when B cells are stimulated with anti-Ig antibodies. Both types of stimulation protocols lead to different B-cell fates, which is a new finding.
32. C. Pan, N. Baumgarth, and J.R. Parnes CD72-deficient mice reveal nonredundant roles of CD72 in B cell development and activation Immunity 11 1999 495 506
33. H.J. Wu, C. Venkataraman, S. Estus, C. Dong, R.J. Davis, R.A. Flavell, and S. Bondada Positive signalling through CD72 induces mitogen-activated protein kinase activation and synergizes with B cell receptor signals to induce X-linked immunodeficiency B cell proliferation J Immunol 167 2001 1263 1273
34. M. Ogimoto, G. Ichinowatari, N. Watanabe, N. Tada, K. Mizuno, and H. Yakura Impairment of B cell receptor-mediated Ca2+ influx, activation of mitogen-activated protein kinases and growth inhibition in CD72-deficient BAL-17 cells Int Immunol 16 2004 971 982
35. N. Fujiwara, N. Fusaki, and N. Hozumi CD72 stimulation modulates anti-IgM induced apoptotic signalling through the pathway of NF-kappaB, c-Myc and p27(Kip1) Microbiol Immunol 48 2004 59 66
36. A. Kumanogoh, C. Watanabe, I. Lee, X. Wang, W. Shi, H. Araki, H. Hirata, K. Iwahori, J. Uchida, and T. Yasui Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: a novel mechanism for regulating B cell signalling Immunity 13 2000 621 631
37. A. Elhabazi, S. Delaire, A. Bensussan, L. Boumsell, and G. Bismuth Biological activity of soluble CD100. I. The extracellular region of CD100 is released from the surface of T lymphocytes by regulated proteolysis J Immunol 166 2001 4341 4347
38. W. Shi, A. Kumanogoh, C. Watanabe, J. Uchida, X. Wang, T. Yasui, K. Yukawa, M. Ikawa, M. Okabe, and J.R. Parnes The class IV semaphorin CD100 plays nonredundant roles in the immune system: defective B and T cell activation in CD100-deficient mice Immunity 13 2000 633 642
39. M. Blery, H. Kubagawa, C.C. Chen, F. Vely, M.D. Cooper, and E. Vivier The paired Ig-like receptor PIR-B is an inhibitory receptor that recruits the protein-tyrosine phosphatase SHP-1 Proc Natl Acad Sci USA 95 1998 2446 2451
40. T. Takai, and M. Ono Activating and inhibitory nature of the murine paired immunoglobulin- like receptor family Immunol Rev 181 2001 215 222
41. L.H. Ho, T. Uehara, C.C. Chen, H. Kubagawa, and M.D. Cooper Constitutive tyrosine phosphorylation of the inhibitory paired Ig-like receptor PIR-B Proc Natl Acad Sci USA 96 1999 15086 15090
42. A. Maeda, M. Kurosaki, M. Ono, T. Takai, and T. Kurosaki Requirement of SH2-containing protein tyrosine phosphatases SHP-1 and SHP-2 for paired immunoglobulin-like receptor B (PIR-B)-mediated inhibitory signal J Exp Med 187 1998 1355 1360
43. -/-) mice Nat Immunol 3 2002 542 548
44. -/- mice.
45. S. Liang, B. Baibakov, and A. Horuzsko HLA-G inhibits the functions of murine dendritic cells via the PIR-B immune inhibitory receptor Eur J Immunol 32 2002 2418 2426
46. T. Muta, T. Kurosaki, Z. Misulovin, M. Sanchez, M.C. Nussenzweig, and J.V. Ravetch A 13-amino-acid motif in the cytoplasmic domain of Fc gamma RIIB modulates B-cell receptor signalling Nature 368 1994 70 73
47. M. Ono, S. Bolland, P. Tempst, and J.V. Ravetch Role Of the Inositol Phosphatase SHIP In Negative Regulation Of the Immune System By the Receptor Fc-gamma-RIIB Nature 383 1996 263 266
48. I. Isnardi, R. Lesourne, P. Bruhns, W.H. Fridman, J.C. Cambier, and M. Daeron Two distinct tyrosine-based motifs enable the inhibitory receptor FcgammaRIIB to cooperatively recruit the inositol phosphatases SHIP1/2 and the adapters Grb2/Grap J Biol Chem 279 2004 51931 51938
49. A. Brauweiler, I. Tamir, J. Dal Porto, R.J. Benschop, C.D. Helgason, R.K. Humphries, J.H. Freed, and J.C. Cambier Differential regulation of B cell development, activation, and death by the src homology 2 domain-containing 5′ inositol phosphatase (SHIP) J Exp Med 191 2000 1545 1554
50. M. Ono, H. Okada, S. Bolland, S. Yanagi, T. Kurosaki, and J.V. Ravetch Deletion of SHIP or SHP-1 reveals two distinct pathways for inhibitory signalling Cell 90 1997 293 301
51. I. Tamir, J.C. Stolpa, C.D. Helgason, K. Nakamura, P. Bruhns, M. Daeron, and J.C. Cambier The RasGAP-binding protein p62dok is a mediator of inhibitory FcgammaRIIB signals in B cells Immunity 12 2000 347 358
52. K.S. Brown, D. Blair, S.D. Reid, E.K. Nicholson, and M.M. Harnett FcgammaRIIb-mediated negative regulation of BCR signalling is associated with the recruitment of the MAPkinase-phosphatase, Pac-1, and the 3′-inositol phosphatase, PTEN Cell Signal 16 2004 71 80
53. A. Ujike, Y. Ishikawa, M. Ono, T. Yuasa, T. Yoshino, M. Fukumoto, J.V. Ravetch, and T. Takai Modulation of immunoglobulin (Ig)E-mediated systemic anaphylaxis by low-affinity Fc receptors for IgG J Exp Med 189 1999 1573 1579
54. A. Nakamura, T. Yuasa, A. Ujike, M. Ono, T. Nukiwa, J.V. Ravetch, and T. Takai Fcgamma receptor IIB-deficient mice develop Goodpasture's syndrome upon immunization with type IV collagen: a novel murine model for autoimmune glomerular basement membrane disease J Exp Med 191 2000 899 906
55. S. Bolland, and J.V. Ravetch Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis Immunity 13 2000 277 285
56. T. Moll, L. Nitschke, M. Carroll, J.V. Ravetch, and S. Izui A critical role for Fc gamma RIIB in the induction of rheumatoid factors J Immunol 173 2004 4724 4728
57. R.N. Pearse, T. Kawabe, S. Bolland, R. Guinamard, T. Kurosaki, and J.V. Ravetch SHIP recruitment attenuates Fc gamma RIIB-induced B cell apoptosis Immunity 10 1999 753 760
58. A.M. Brauweiler, and J.C. Cambier Autonomous SHIP-dependent FcgammaR signalling in pre-B cells leads to inhibition of cell migration and induction of cell death Immunol Lett 92 2004 75 81
59. T.L. McGaha, B. Sorrentino, and J.V. Ravetch Restoration of tolerance in lupus by targeted inhibitory receptor expression Science 307 2005 590 593
60. R.S. Davis, G.R. Ehrhardt, C.M. Leu, M. Hirano, and M.D. Cooper An extended family of Fc receptor relatives Eur J Immunol 35 2005 674 680